The global respiratory diagnostics market, valued at US$ 5.85 billion in 2023, is forecasted to grow at a robust CAGR of 6.5% ...

Roland Head explains why he thinks these penny stocks have the potential to deliver long-term winning returns if investors ...

The global respiratory diagnostics market, valued at US$ 5.85 billion in 2023, is forecasted to grow at a robust CAGR of 6.5%, reaching US$ 6.17 billion in 2024 and an impressive US$ 9.02 billion by ...

Colds – also known as “flu-like infections” – are caused by a variety of viruses. More than 200 pathogens can be involved, ...

The time from when a person is exposed to avian flu to when they develop symptoms is about three days but can range from two to seven days. Eye symptoms such as redness and irritation can be one of ...

The founding director of the FDA’s Office of Biotechnology writes that new evidence suggests COVID may be a novel, additional ...

The inhaled monoclonal antibody IN-006 shows promise in COVID-19 treatment, with high airway antibody levels and a favorable safety profile in healthy adults.

The pandemic death total stands at 1,252 as of February 1, 2025 (the most recent data available). The 5 reported deaths last ...

If all this sounds familiar, you’re probably thinking of Theranos, but SiPhox says their product really works and could be in ...

Mainz Biomed N.V. (NASDAQ:MYNZ) ("Mainz Biomed" or the "Company"), a molecular genetics diagnostic company specializing in the early ...